throbber
Page 1
`
` UNITED STATES PATENT AND TRADEMARK OFFICE
` BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`___________________________________
` )
`SMITH & NEPHEW, INC., ) Case No.
` ) IPR2013-00629
` Petitioner, )
` ) Patent 7,806,896
` vs. )
` )
`BONUTTI SKELETAL INNOVATIONS LLC, )
` )
` Patent Owner. )
`___________________________________)
`
` TUESDAY, MAY 13, 2014
`
` VIDEOTAPED deposition of JAY B. MABREY, M.D.,
`taken at the offices of 1875 Pennsylvania Ave NW,
`Washington, D.C. beginning at 9:14 A.M., before
`Nancy J. Martin, a Registered Merit Reporter,
`Certified Shorthand Reporter.
`
`Exhibit 2003
`Smith & Nephew v.
`Bonutti Skeletal
`Innovations LLC
`Trial: IPR2013-00629
`
`212-279-9424
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`12
`
`3
`
`45
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`

`

`Page 2
`
`A P P E A R A N C E S :
` DAVIDSON, DAVIDSON & KAPPEL, LLC
` BY: CARY KAPPEL, ESQUIRE
` DAVID PETROFF, ESQUIRE
` 485 Seventh Avenue
` 14th Floor
` New York, New York 10018
` (212) 736-1940
` Representing Bonutti Skeletal Innovations
` LLC
`
` WILMER CUTLER PICKERING HALE and DORR LLP
` BY: JACOB S. OYLOE, ESQUIRE
` MICHAEL H. SMITH, ESQUIRE
` JAMES M. DOWD, ESQUIRE
` 1875 Pennsylvania Avenue NW
` Washington, D.C. 20006
` (202) 663-6093
` Representing Smith & Nephew and the
` deponent
` ALSO PRESENT:
` KIM JOHNSON, Legal Videographer
`
`12
`
`3
`4
`5
`6
`7
`
`89
`
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-279-9424
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 3
`
` I N D E X
`TESTIMONY OF: JAY B. MABREY, M.D.
`BY MR. KAPPEL....................................6
`BY MR. OYLOE....................................87
`BY MR. KAPPEL...................................94
`
` - - -
` E X H I B I T S
` - - -
`NUMBER DESCRIPTION MARKED
`Exhibit BSI 2001 Geometric and Anametric 66
` Total Knee Replacement,
` Pages 180 and 181, 2 pages
`Exhibit BSI 2002 Figure 18 (Aand ) Sizing of 99
` the femoral implant and
` establishing formal component
` rotating during the mechanical
` technique, 1 page
`
`12
`
`3
`4
`5
`6
`
`78
`
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-279-9424
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 4
`
` DEPOSITION SUPPORT INDEX
`
`DIRECTION TO WITNESS NOT TO ANSWER
`Page Line
`
`REQUEST FOR PRODUCTION OF DOCUMENTS
`Page Line
`
`QUESTIONS MARKED:
`Page Line
`
`12
`
`34
`
`5
`
`6789
`
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-279-9424
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 5
`
` WASHINGTON, D.C., TUESDAY, MAY 13, 2014; 9:14 A.M.
` -OoO-
` THE VIDEOGRAPHER: My name is Kim Johnson
`representing Veritext. The date today is May 13,
`2014. The time is 9:14. This deposition is being
`held at WilmerHale located at 1875 Pennsylvania
`Avenue, Washington, D.C. The caption of this case is
`Smith & Nephew, Incorporated, v. Bonutti Skeletal
`Innovations, LLC. This case is filed in the U.S.
`Patent and Trademark Office before the Patent Trial
`and Appeal Board. Case No. IPR2013-00629. The name
`of the witness is Jay Mabrey.
` At this time, the attorneys present in the
`room will identify themselves and the parties they
`represent.
` MR. KAPPEL: Cary Kappel, Davidson Davidson &
`Kappel, representing Bonutti Skeletal Innovations.
` MR. PETROFF: David Petroff, Davidson
`Davidson & Kappel representing Bonutti Skeletal.
` MR. OYLOE: Jake Oyloe, WilmerHale,
`representing Smith & Nephew and the witness.
` MR. SMITH: Michael Smith, WilmerHale,
`representing Smith & Nephew and the witness.
` MR. DOWD: Jim Dowd, WilmerHale.
`
`12
`
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-279-9424
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 6
`
` THE VIDEOGRAPHER: And our court reporter,
`Nancy Martin, representing Veritext, will swear in the
`witness and we can proceed.
` - - -
` JAY B. MABREY, M.D., after having been
` first duly sworn, was examined and testified as
` follows:
`
` EXAMINATION
`BY MR. KAPPEL:
` Q. Good morning, Dr. Mabrey.
` A. Good morning.
` Q. My name is Cary Kappel, and I represent the
`plaintiff -- the defendant in this case. Can you
`state your full name for the record.
` A. Jay Donald Mabrey.
` Q. During the course of this deposition I'll be
`asking you some questions. All you have to do is
`answer them truthfully and completely. If I ask you a
`question that doesn't make sense to you or is
`confusing, just let me know and I'll try to rephrase
`it. During the course of the deposition, your
`attorney may object from time to time. You should let
`him finish his objection before you answer because we
`
`12
`
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-279-9424
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 7
`
` JAY D. MABREY, M.D.
`have a court reporter here, and she can't type down
`two people speaking at once. So, also, if I'm asking
`a question, let me finish before you start so that we
`don't have a confusing record. Is that okay?
` A. Okay. Fine.
` MR. KAPPEL: Let me hand you what has been
`previously marked as Exhibit S&N 1002.
` (Previously marked Exhibit 1002.)
`BY MR. KAPPEL:
` Q. Do you recognize this document?
` A. Yes.
` Q. And it is Exhibit 1002, a copy of the
`declaration signed by you?
` A. Yes.
` Q. I'd like you to turn to the Appendix A at the
`back of Exhibit 1002. It's actually separately
`stapled, if that makes it easier for you.
` A. Yes.
` Q. And is Appendix A a copy of your curriculum
`vitae?
` A. Yes.
` Q. And is that -- is this CV current as of
`today?
` A. Yes.
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-279-9424
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 8
`
` JAY D. MABREY, M.D.
` Q. Okay. Have you ever served as an expert
`witness before?
` A. Yes.
` Q. Okay. How many cases have you served as an
`expert witness?
` A. One or two. It's been over several years.
` Q. Okay. And were these -- were those one or
`two cases patent cases?
` A. The first one was, yes.
` Q. And what was the subject matter of the other
`case?
` A. I believe there was medical liability.
` Q. Let's start with the patent case. What was
`the technology involved in that case?
` A. A pneumatic compression foot pump. The
`parties involved were KCI v. Kinnamed.
` Q. Can you spell the second party?
` A. K-i-n-n-a-m-e-d.
` Q. And were you deposed in that case?
` A. No.
` Q. Did you ever testify in court in that case?
` A. No.
` Q. In the medical liability case, what were the
`parties involved, if you recall?
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-279-9424
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 9
`
` JAY D. MABREY, M.D.
` A. It involved a hip implant.
` Q. Okay. And were you deposed in that case?
` A. No.
` Q. And did you testify in court at all in that
`case?
` A. No.
` Q. Have you ever been deposed in any proceeding?
` A. Yes.
` Q. If you can recall, how many times you have
`been deposed?
` A. Two or three times.
` Q. But those were not -- I presume those were
`not cases in which you were serving as an expert
`witness?
` A. Correct.
` Q. So you were a fact witness in those cases?
` A. Correct.
` Q. Have you ever had occasion to submit any --
`well, let me recouch that. Leaving aside inter partes
`reviews that you have worked on for Smith & Nephew,
`have you submitted any other declarations to the
`United States Patent Office in any other proceedings?
` A. I have not, no.
` Q. Do you currently teach at Texas A&M?
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-279-9424
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 10
`
` JAY D. MABREY, M.D.
` A. I teach at Baylor University Medical Center,
`and I am a professor of surgery at Texas A&M, and I
`hold that title because Texas A&M medical students
`rotate through our facility. So I don't teach at
`Texas A&M.
` Q. Okay. So they rotate through the facility at
`Baylor; is that --
` A. In Dallas, correct.
` Q. Okay. All right. So describe for me what
`your responsibilities are at Baylor as the chief -- or
`where you're teaching at Baylor.
` A. I'm the chief of orthopedic surgery, and I
`oversee educational activities at the medical center.
`I serve on several committees and also serve as system
`champion for various aspects of medical care, such as
`the electronic health record and best practices. I
`interface with all the practicing surgeons and also
`conduct a tri-monthly grand rounds staff meeting, and
`I also conduct an advisory council every three months
`as well. I'm at the disposal of the president of the
`hospital and the president of the healthcare system as
`a resource for anything regarding orthopedics.
` I have medical students that rotate through
`my practice. They come to my clinic and to my
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-279-9424
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 11
`
` JAY D. MABREY, M.D.
`operating room. We have orthopedic residents who
`rotate through our clinic and operating rooms from the
`University of Texas Southwestern, and I'm responsible
`for teaching them when they're in my presence. And I
`also have a clinical practice that focuses on hip and
`knee replacement.
` Q. Okay. Describe for me, on a day-to-day
`basis, what your clinical practice involves.
` MR. OYLOE: Objection to form.
` THE WITNESS: I have a private practice with
`one partner. I have clinic 2-1/2 days a week. At
`those clinics I receive referrals from all over the
`healthcare system and from a three or four statewide
`area. My clinical practice focuses on total hip and
`total knee replacement, total hip revision, knee
`revision, knee arthroscopy and hip arthroscopy.
`During those clinics I see referrals from the Health
`Texas Provider Network. I treat a variety of
`conditions, but I focus on hip and knee. On days that
`I'm not in my clinic I have 2-1/2 days of operating
`room. Mondays I perform hip and knee arthroscopy, and
`then Wednesdays and Fridays are full days devoted to
`hip and knee replacement, hip and knee revision,
`gluteal tendon repair.
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-279-9424
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 12
`
` JAY D. MABREY, M.D.
`BY MR. KAPPEL:
` Q. In your previous answer you made a
`distinction between knee replacement and knee
`revision.
` A. Yes.
` Q. Can you explain for me what each entails and
`how they differ?
` A. Total knee replacement involves the de novo
`replacement of an arthritic or injured knee joint with
`a metal and polyethylene prosthesis. Total knee
`revision involves the repair or replacement of an
`existing total knee replacement with another knee
`replacement or the removal of that existing knee
`replacement for infection and replacement with a
`polymethyl methacrylate spacer.
` REPORTER MARTIN: With a what? I'm sorry.
`Poly?
` THE WITNESS: Polymethyl methacrylate. You
`could write PMMA.
` REPORTER MARTIN: I'm sorry.
` MR. KAPPEL: It's okay.
` Q. Okay. Turning to the second page of your CV,
`I noticed that it indicates that you presently consult
`or work for Parcell Labs, Exactech, and Mabrey Medical
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-279-9424
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 13
`
` JAY D. MABREY, M.D.
`Templates; is that correct?
` A. Correct.
` Q. What are your current responsibilities at
`Parcell Labs?
` MR. OYLOE: Objection to form.
` THE WITNESS: For Parcell Labs I serve as a
`consultant in obtaining human synovial tissue.
`Actually, human synovial fluid at the time of primary
`total knee replacement. Parcell Labs then takes that
`fluid and extracts the stem cells to produce a
`commercial product. I'm not involved in the
`development of the product. The president of the
`company is a friend, and I offered to help her with
`that.
`BY MR. KAPPEL:
` Q. Okay. I see you list your position at
`Exa- -- as Exactech as "design consultant"; is that
`correct?
` A. Yes.
` Q. What is the nature of your work for Exactech?
` A. Two products. The first product is the CR
`Plus cruciate retaining knee. This is a knee
`replacement that has a variable slope polyethylene
`insert, and I was on the original design team for that
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-279-9424
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 14
`
` JAY D. MABREY, M.D.
`product.
` The second area that I'm consulting is on the
`Logitech posterior stabilized knee with a modular
`cross bar.
` And the third project I'm involved with is
`the GPS guidance system for Exactech for performing
`total knee replacement. Computer navigation.
` Q. Finally, I see -- well, you list yourself as
`CEO of Mabrey Medical Templates from 1989 --
` A. Yes.
` Q. -- to the present; is that correct?
` A. Yes.
` Q. And what is the nature of your work for
`Mabrey Medical Templates?
` A. It's medical art. I started back -- as a
`company to produce templates, literally plastic
`templates with the outlines of various anatomical
`parts to aid physicians describing injuries in the
`emergency room or describing their surgeries, as we
`would cut out these plastic templates, and they were
`sold at medical schools. Now, with the advent of the
`electronic medical record, that has fallen by the
`wayside, and now I focus on computer graphics and
`animation of surgical procedures using animation
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-279-9424
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 15
`
` JAY D. MABREY, M.D.
`software.
` Q. Okay. You seem to have a lot of activity.
`So let me ask you if I've missed any other
`professional activities that you are currently
`involved in?
` A. None, other than my official functions as the
`chief of orthopedics and as a professor of orthopedic
`surgery.
` Q. Okay. On Page 2 of your CV you note that you
`consulted for Howmedica between 1995 and 1997; is that
`correct?
` A. Correct.
` Q. And describe for me the work that you did for
`Howmedica.
` A. I was basically on surgeon panels and
`provided them with feedback for various adult
`reconstruction products.
` Q. Can you list for me the products that you can
`recall?
` A. There were several. I remember one was a
`hydroxyapatite coated acetabular component.
` Q. Let me back up. So what exactly is that used
`for?
` A. That's used in total hip replacement, and the
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-279-9424
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 16
`
` JAY D. MABREY, M.D.
`acetabular component is a dome shaped piece of metal
`that fits into the pelvis and receives the head of the
`prosthesis. Hydroxyapatite is a bone-like coating and
`encourages on-growth of bone onto the implant and
`stabilizes it. What I remember, I wasn't impressed.
`It was rubbing off on my fingers.
` Q. Okay. Did you do any -- did you do any
`consulting work regarding any knee replacement
`products for Howmedica?
` A. No, none that I can recall.
` Q. Okay. And continuing on Page 2 of your CV, I
`note that you were a consultant for Smith & Nephew
`between 1991 and 1997; is that correct?
` A. Yes.
` Q. Describe for me the work that you did for
`Smith & Nephew in that time frame.
` A. I served as a lecturer at some of their
`medical meetings and also an instructor at some of
`their cadaver labs.
` Q. So in the cadaver labs you were providing
`instruction to other physicians; is that correct?
` A. Overseeing surgery at the time, yes.
` Q. And what types of surgeries were you
`overseeing?
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-279-9424
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 17
`
` JAY D. MABREY, M.D.
` A. Total hip replacement.
` Q. Again, on Page 2 of your CV I see that you
`consulted for -- and I'll mispronounce this for sure.
`DePuy.
` A. DePuy.
` Q. DePuy. Easier than I thought. Between 2000
`and 2004; is that correct?
` A. Correct.
` Q. And please describe for me the work that you
`did for DePuy in that time frame.
` A. I was asked to provide feedback on their
`surgical robotics system. It was a knee navigation
`system.
` Q. From your previous answers I gather that you,
`over your career, performed told knee replacement
`surgeries; is that correct?
` A. Yes.
` Q. When did you first perform a total knee
`replacement surgery? I don't need an actual date, but
`approximate year will be fine.
` A. Can you clarify "participate" or conduct as
`the primary surgeon?
` Q. Let's start with participate in a total knee
`replacement surgery.
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-279-9424
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 18
`
` JAY D. MABREY, M.D.
` A. 1978.
` Q. And was that while you were in medical
`school?
` A. Yes.
` Q. And when was the first occasion -- again,
`just year will be fine -- that you were a primary
`physician at total knee replacement surgery?
` A. 1985, 1986.
` Q. When was the first time you were a primary
`physician at partial knee replacement surgery?
` MR. OYLOE: Objection to form.
` THE WITNESS: To the best of my recollection,
`I was not part of that partial knee replacement -- or
`not involved in the partial knee replacement.
`BY MR. KAPPEL:
` Q. Okay. So let's back up. Have you ever
`performed a partial knee replacement?
` A. No.
` Q. On your CV on Page 2, you list work for
`Source Medical as a consultant between 2001 and 2004;
`is that correct?
` A. Yes.
` Q. Describe for me the work that you did for
`Source Medical.
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-279-9424
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 19
`
` JAY D. MABREY, M.D.
` A. I was asked to provide comments on their
`plans for a physical therapy program. I don't believe
`I received any compensation for that.
` Q. What type of physical therapy program were
`you advising on?
` A. For hip and knee replacements.
` Q. Approximately how many -- well, let's start
`in the present day. Can you tell me in --
`approximately how many total knee replacement
`surgeries did you perform as a primary physician in
`2003 -- I'm sorry -- 2013?
` A. Between 80 and 100.
` Q. And would that estimate of 80 to 100 in a
`year be accurate for prior years as well?
` A. The year before, most likely.
` Q. Were there years in which you think you
`performed far less than that?
` A. Yes.
` Q. Okay. What years would those be?
` A. 2004 I was recruited to become the chief of
`orthopedics at Baylor University Medical Center, which
`is in a new city and I had to basically establish a
`new orthopedic practice.
` Q. Is there a particular brand and model of knee
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-279-9424
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 20
`
` JAY D. MABREY, M.D.
`prosthesis that you use in your practice?
` MR. OYLOE: Objection. Compound.
` THE WITNESS: Are you asking for all
`prostheses?
`BY MR. KAPPEL:
` Q. Yes. Tell me.
` MR. OYLOE: Same objection.
` THE WITNESS: In my practice I use knee
`prostheses from Exactech, based in Gainesville,
`Florida. Smith & Nephew, based in Memphis, Tennessee,
`and DePuy Johnson & Johnson, Warsaw, Indiana.
` REPORTER MARTIN: Where in Indiana?
` THE WITNESS: Warsaw, Indiana.
`BY MR. KAPPEL:
` Q. Turning to Page 7 of your declaration,
`paragraph 13 you state that you are being compensated
`at your normal consulting rate for your work; is that
`correct?
` A. Correct.
` Q. And what is that rate?
` A. $500 per hour.
` Q. Approximately how much time did you spend
`preparing your declaration?
` A. 30, 35, 40 hours.
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-279-9424
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 21
`
` JAY D. MABREY, M.D.
` Q. Please describe for me the steps that you
`took in preparing the declaration.
` MR. OYLOE: Objection. I'll just caution you
`that you can discuss the drafting, but don't reveal
`any communications with counsel.
` THE WITNESS: I reviewed the patents in
`question, and I performed independent research at two
`separate medical libraries. I performed on-line
`searches and I -- through Google and the on-line
`medical database. I then retrieved papers, chapters
`of books, made copies, and reviewed those and then
`reviewed my findings with counsel.
`BY MR. KAPPEL:
` Q. Are you familiar with the term "prosecution
`history" as it relates to a patent?
` A. No.
` Q. Okay. Did you review a record of the
`proceedings before the patent office that led to the
`granting of U.S. Patent 7,806,894?
` MR. OYLOE: Objection to form.
` THE WITNESS: I reviewed multiple documents.
`I don't remember assigning them a particular title.
` (Pause in proceedings.)
` MR. KAPPEL: I'm going to hand you what's
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-279-9424
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 22
`
` JAY D. MABREY, M.D.
`been previously marked as Exhibit S&N 1014.
` (Previously marked Exhibit 1014.)
` (The witness reviewed Exhibit 1014.)
`BY MR. KAPPEL:
` Q. Do you recognize this document?
` A. No, I don't.
` MR. KAPPEL: I'd like to refer you to
`Exhibit 1002, which is your declaration at Page 22.
`And, in particular, the end of Paragraph 45.
` (The witness reviewed Exhibit 1002.)
`BY MR. KAPPEL:
` Q. Do you see that passage?
` A. Yes.
` Q. And do you see the reference to "'896 patent
`file history, April 30, 2007, Response, Page 13
`(Exhibit 1014)." Do you see that?
` A. Yes.
` Q. Okay. A moment ago you told me you didn't
`know -- have an understanding of the word -- well,
`actually, let me rephrase that because I said
`"prosecution history."
` What did you mean by "the patent file
`history" at the end of Paragraph 45?
` MR. OYLOE: Objection to form.
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-279-9424
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 23
`
` JAY D. MABREY, M.D.
` THE WITNESS: Most likely, terminology
`provided to me by counsel as part of our collaborative
`effort.
`BY MR. KAPPEL:
` Q. Okay. So you couldn't tell me, sitting here
`today, what a patent file history is?
` MR. OYLOE: Objection to form.
` THE WITNESS: I don't recall the term.
`BY MR. KAPPEL:
` Q. So you do not know what is in a patent file
`history other than, I guess, Exhibit 1014?
` MR. OYLOE: Objection. Mischaracterizes.
` THE WITNESS: Whatever the contents were that
`I reviewed months ago.
`BY MR. KAPPEL:
` Q. Did you review Exhibit 1014 during the course
`of preparing your declaration?
` MR. OYLOE: Objection to form.
` THE WITNESS: I did at some point, months
`ago. I don't remember the time offhand.
`BY MR. KAPPEL:
` Q. Do you know whether or not you reviewed any
`other portion of the patent file history while you
`were preparing this report?
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-279-9424
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 24
`
` JAY D. MABREY, M.D.
` MR. OYLOE: Objection to form.
` THE WITNESS: I'm sorry. Could you clarify
`what you mean by "any other part of the patent file
`history."
`BY MR. KAPPEL:
` Q. Do you know whether or not Exhibit 1014 is
`the only documents in the '896 patent file history?
` MR. OYLOE: Objection to form.
` THE WITNESS: I know I reviewed several
`documents in the past, and I have not memorized them.
` MR. KAPPEL: I'm handing you what's been
`previously marked as Exhibit S&N 1001, which is
`United States Patent Number 7,806,896.
` (Previously marked Exhibit 1001.)
` (The witness reviewed Exhibit 1001.)
`BY MR. KAPPEL:
` Q. Do you recognize that document?
` A. Yes, I do.
` Q. Is this a document that you reviewed in
`preparation -- in preparing your declaration?
` A. Yes, it is.
` Q. Have you read the entirety of Exhibit 1001?
` A. At one point I went through the entire
`document.
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-279-9424
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 25
`
` JAY D. MABREY, M.D.
` Q. How many times would you say you read through
`Exhibit 1001?
` A. Twice perhaps.
` Q. I'd like to refer you to your declaration,
`Exhibit 1002, Page --
` MR. KAPPEL: Why don't we take a five-minute
`break.
` MR. OYLOE: Okay.
` THE VIDEOGRAPHER: Off the record at 10:01.
` (A recess was taken from 10:01 a.m.
` to 10:08 a.m.)
` THE VIDEOGRAPHER: We are back on the record
`at 10:08.
` MR. KAPPEL: Dr. Mabrey, I'd like to refer
`you to Paragraph 16 of your declaration, which is on
`Page 7. And the last sentence of Paragraph 16 reads,
`"This definition is consistent with the '896 patent
`specification," and you cite to the '896 patent's"
`Column 38, Lines 9 to 18.
` Q. Is that correct?
` A. Yes.
` Q. And did you choose that citation or that
`passage in your declaration?
` MR. OYLOE: Objection to form.
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-279-9424
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 26
`
` JAY D. MABREY, M.D.
` THE WITNESS: Yes.
`BY MR. KAPPEL:
` Q. Why did you choose that passage?
` MR. OYLOE: Objection to form.
` (The witness reviewed the document.)
` THE WITNESS: Just to define the term
`"guide." He refers to the "femoral cutting guide,"
`"tibial resection guide" in Lines 14 and 15.
`BY MR. KAPPEL:
` Q. How does that tell you that a cutting guide
`should be a guide that has a guide surface and that
`the term "guide surface" should mean a surface that
`guides a cutting instrument?
` MR. OYLOE: Objection to form.
` THE WITNESS: That's my definition of a
`guide. That's the way I use it in my practice.
`BY MR. KAPPEL:
` Q. This passage that you cited does not include
`the term "guide surface," does it?
` A. It doesn't use the word "surface," no.
` Q. When we spoke previously, I believe you
`stated you spent 30 to 35 hours preparing this
`declaration; is that correct?
` MR. OYLOE: Objection. Mischaracterizes.
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-279-9424
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 27
`
` JAY D. MABREY, M.D.
`BY MR. KAPPEL:
` Q. How much time did you spend -- I'll withdraw.
` How much time do you estimate you spent
`preparing this declaration?
` A. Again, I don't remember the exact amount of
`time. Several hours.
` Q. Several?
` A. Yes.
` Q. So it could have been -- what would be the
`range that you would define "several hours"?
` A. 30, 40, 50 hours.
` Q. Okay. And did you draft this declaration?
` MR. OYLOE: Objection to form.
` THE WITNESS: Could you clarify, please.
`BY MR. KAPPEL:
` Q. Did you type the words that are written in
`this declaration?
` A. I did not type this out on my computer.
` Q. Okay. Did you dictate the words to someone
`else who was typing this out on the computer?
` A. I did not dictate.
` Q. I'd like you to describe for me the
`process -- be careful not to disclose any
`attorney-client communication -- of how this 68-page
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-279-9424
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 28
`
` JAY D. MABREY, M.D.
`declaration, the text of it was prepared.
` A. I had several E-mail exchanges with counsel.
`I had several phone exchanges with counsel, and I had
`one in-person meeting with counsel. During that time
`the document was being drafted. My input was on
`paper. I provided feedback and corrected several
`drafts.
` Q. Great.
` I'll refer you to Page 33 of your
`declaration. The second sentence on Page 33 begins,
`"A person of ordinary skill in the art." Do you see
`that?
` A. Yes.
` Q. Please describe for me what you mean by
`"person of ordinary skill in the art."
` MR. OYLOE: Objection to form.
` THE WITNESS: I would define the art here as
`the art of knee replacement surgery, someone with
`ordinary skill in the art would be someone who
`performs knee replacement surgery. Someone who has
`completed with residency and most likely fellowship in
`joint replacement.
`BY MR. KAPPEL:
` Q. When you refer to "a person of ordinary skill
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-279-9424
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 29
`
` JAY D. MABREY, M.D.
`in the art" at Page 33, are you referring to someone
`with that experience today in 2014?
` MR. OYLOE: Objection.
` THE WITNESS: No.
`BY MR. KAPPEL:
` Q. In what time frame would that person have the
`skill you described?
` A. At the time of the Delp article.
` REPORTER MARTIN: Delp?
` THE WITNESS: Delp, D-e-l-p. I'm dropping my
`voice again. Sorry.
` MR. KAPPEL: I'd like to refer you now to
`Paragraph 45 of your declaration, which is on Page 22.
`That paragraph begins "Of the 112 columns of material
`in the specification, only a few description
`paragraphs even arguably relate to the purportedly
`novel features of the claimed invention."
` Q. Do you see that?
` A. Yes.
` MR. OYLOE: Can I just -- sorry to interrupt.
`What page number again?
` MR. KAPPEL: 22.
` MR. OYLOE: 22. Sorry.
`BY MR. KAPPEL:
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-279-9424
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 30
`
` JAY D. MABREY, M.D.
` Q. Please list for me the paragraphs that you
`are referring to in that sentence.
` MR. OYLOE: Objection to form.
` THE WITNESS: So that would be Column 3,
`Paragraph 4. "A cut on a bone in the patient may be
`completed using previously cut surfaces as a guide for
`the cutting tool."
`BY MR. KAPPEL:
` Q. Okay. Now, continuing on Paragraph 45 of
`your declaration, you continue, and that's "Applicant
`appears to have relied -- without explanation -- on
`this disclosure for the conclusion that: 'The present
`invention provides a means for cutting bone, where the
`guide member is free of extramedullary or
`intramedullary members.'" Do you see that?
` A. Yes.
` Q. And is that what you call the purportedly
`novel features that you're referring to in the first
`sentence of Paragraph 45?
` MR. OYLOE: Objection. Form.
` THE WITNESS: One of the purpor

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket